Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atazanavir Switch Study for Hyperlipidemia in HIV
NCT00067782Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2002
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Started Dec 2002; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00067782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00067782.